The US market is increasingly hot on biosensor mobile medical projects. From the product side ( medical device company), the service side (hospital) to the payer (insurance company), and the platform side (Google, Apple), are optimistic about this area.
Biosensing products monitor some of the user's health indicators in real time through sensors or devices. The biosensing products come in many forms, from wearable devices (such as wristbands) to implanted devices. (As mentioned in the lung detector Cardiomems), it may also be smart clothing with sensing function and sensor patch.
The first medical device company interested in biosensing products. Notable acquisitions in recent years include Medtronic's $150 million acquisition of Corventis, a sensory wearable device that detects arrhythmia, StJudeMedical's $60 million acquisition of implanted pulmonary artery detector Cardiomems, and Covidien's acquisition of heart rate sensing monitoring equipment provider Zephyr.
Most of the acquired projects are very professional, special research and development for a particular medical field, the core of the design is the accuracy and continuity of data collection, can help doctors make judgments. With the increasing difficulty in the development of traditional medical devices and fierce competition, medical device companies are optimistic about the future application potential of such new types of projects.
In addition to this, there are also payers (mainly insurance companies) and hospitals. For the payer, the most important thing is two points. The first is the effectiveness of the product. Insurance companies are most concerned about controlling medical costs by helping members control disease development. If a product that helps record user health indicators can urge users to take immediate action when physical conditions change, or to influence users in a subtle manner, help them maintain A healthy lifestyle, then the insurance company is very motivated to put these items in the bag and provide it to members as part of the insurance plan. Secondly, the simplicity of these products, the products that do not affect normal life for users, and the use and data collection are very simple.
For hospitals, biosensing products help them collect real-time data from more patients in certain complex areas, especially chronic diseases such as heart disease and high blood pressure that require long-term follow-up. It is very helpful for the whole treatment. But the hospital is most concerned about the accuracy of these products and the ease of data collection. The hospital will require a high degree of precision in assisted clinical products, many of which need to be approved by the FDA for clinical use. At the same time, doctors are unlikely to spend a lot of time sorting and analyzing data, so the more intuitive the data, the easier it is for doctors to accept.
From the current development of biosensing mobile medical products , the market is very fragmented. There are a lot of small startups, and the areas in which the projects are focused are very different. In the future, the dispersion of such products will continue. However, the giants have begun to pay attention to the potential of these mobile medical data collection fields, and hope to establish a platform for software, hardware and data. For example, Apple's HealthKit has a partner that is the health care file provider Epic. The goal of the two companies is to create a mobile medical data platform. The future trend is that these distributed software can transfer data through a platform and then share or store it. Platform integration on hardware is also a trend. Hardware data can be transmitted and stored through the platform, incorporated into personal health files and shared with doctors.
The difference between a professional biosensing device and a common wearable device is that it can be used as a part of personal health indicators to assist the doctor's judgment. Therefore, the significance of this platform integration is of great significance to professional biosensing devices, which can integrate scattered medical data into personal health files and share them with doctors.
To sum up, all aspects of the medical industry , from the product side (medical device company), the service side (hospital) to the payer (insurance company), are optimistic about the potential of biosensing professional products, and the emergence of the platform side (Apple, Google) may quickly push the actual clinical application of these previously dispersed health data.
3mm Pediatric Laparoscopic Forceps
3mm Pediatric Laparoscopic Forceps,Pediatric Laparoscopic Forceps,Pediatrics Curved Scissors,Laparoscopic Straight Scissors
Tonglu WANHE Medical Instrument Co., Ltd , https://www.vanhurhealth.com